First-time generic drug approvals: Nadolol/bendroflumethiazide and ciprofloxacin
• First-time generic approvals
Nadolol/bendroflumethiazide tablets, 40/5 mg and 80/5 mg (equiv to Corzide tablets)
IMPAX
Ciprofloxacin extended-release tablets, 500 and 1,000 mg (equiv to Cipro XR tablets)
MYLAN
Employers Face Barriers With Adopting Biosimilars
March 1st 2022Despite the promise of savings billions of dollars in the United States, adoption of biosimilars has been slow. A roundtable discussion among employers highlighted some of the barriers, including formulary design and drug pricing and rebates.